---
DrugClass: "[[Cholinergic Blocking Drugs]]"
SubClass: 
DrugClassContra: "[[Cholinergic Blocking Drugs#Contraindications]]"
DrugClassAdverse: "[[Cholinergic Blocking Drugs#Side/Adverse Effects]]"
SecondaryDrugClass: 
SecondarySubClass: 
BrandName: 
Chapter: "26"
KindleLinkChap: "[Chapter 26](kindle://book?action=open&asin=B09FRF11YJ&location=13703)"
KindleLink: 
tags:
  - Drug
  - Pharmacology
Course: Pharmacology
ChemLink: https://pubchem.ncbi.nlm.nih.gov/#query=
---
```smiles
C[N+]1(CCC(C1)OC(=O)C(C2CCCC2)(C3=CC=CC=C3)O)C.[Br-]
```

### Brand name
`=this.BrandName`

### Generic name
`= this.file.name`

### Drug class 
`= this.DrugClass`
	`= this.DrugClass.KindleLinkChap`

### Dosage & Usage
Oral: peptic ulcer Parenteral: in conjunction with anesthesia to reduce bronchial and oral secretions, to block cardiac vagal inhibitory reflexes during [[induction]] of anesthesia and intubation; protection against the peripheral muscarinic effects of cholinergic agents (e.g., neostigmine) 
Oral: 1– 2 mg BID or TID 
Parenteral: peptic ulcer, 0.1– 0.2 mg IM, IV, TID, QID 
Preanesthesia: 0.002 mg/ lb IM Intraoperative: 0.1 mg IV

### Contraindications
See `= this.DrugClassContra`

### Mechanisms of Action

### Side/Adverse Effects
See `= this.DrugClassAdverse`
Blurred [[Vision]], dry [[Mouth]], altered taste perception, nausea, vomiting, dysphagia, urinary hesitancy and retention
### Interactions

`= this.ChemLink+this.file.name`

 